NCT05893173View on ClinicalTrials.gov

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

February 2, 2025

Study Completion Date

February 2, 2025

Conditions
Major Depressive Disorder
Interventions
BEHAVIORAL

Sleep Deprivation

Ten individuals (aged 18-85) with a DSM-V diagnosis of MDD will undergo baseline GluCEST imaging prior to and following approximately 30 hours of total sleep deprivation.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT05893173 - Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation | Biotech Hunter | Biotech Hunter